MENU × BUSINESS
Banking And InsuranceCryptocurrencyDigital MarketingErpFood And BeveragesHealthcareLegalMarketing And AdvertisingMedia And EntertainmentMetals And MiningOil And GasRetailTelecom
TECHNOLOGY
Artificial IntelligenceBig DataCloudCyber SecurityE CommerceEducationGaming And VfxIT ServiceMobileNetworkingSAPScience And TechnologySecuritySoftwareStorage
PLATFORM
CiscoDatabaseGoogleIBMJuniperM2MMicrosoftOracleOracleRed Hat
LEADERSHIP
CEO ReviewCompany Review
MAGAZINE
ASIA INDIA
STARTUPS CLIENT SPEAK CONTACT US

The Silicon Review Asia

IAVI collaborates with Serum to develop antibodies for HIV and other diseases

IAVI collaborates with Serum to develop antibodies for HIV and other diseases

Theinternational AIDS Vaccine Initiative (IAVI) has entered into a strategic partnership with Serum Institute of India in order to manufacture and develop broadly neutralizingmonoclonal antibody (bNAbs) products for HIV and help tackle other global health challenges as well. While the IAVI works with a comprehensive approach that emphasizes the need to develop AIDS and HIV prevention and treatment programs, the Serum Institute of India manufactures immunobiological drugs and vaccines in India.

Mark Feinberg, IAVI president and CEO, says that this partnership is expected to bring both the organisations to a position where they will invent a viable and sustainable pathway to manufacture antibody-based products that are affordable and accessible for all. If this works out, they also have plans to apply their innovative monoclonal antibody therapeutics to target other diseases. According to a statement made by Adar Poonawalla, CEO of Serum Institute of India, the company has a set a benchmark globally with its vaccines and pharmaceutical products, and now, it is already in the process of utilising this expertise in the antibody development space.

He mentioned, “Serum Institute and IAVI have joined forces in the fight against HIV with the aim of making cost-effective monoclonal antibodies for HIV, and in the fields of antimicrobial resistance and anti-snake venom. Provided the breadth of our technology, I am confident that we will be able to make positive contributions in these important areas.” IAVI with its partners also hopes to explore strategies by which it can directly deliver bNAbs to prevent HIV infection.

YOU MAY ALSO LIKE

Marketing Partnership: NBA, McDonald’s Will Jointly open NBA Experience Zones India

There is good news for all basketball fans in India. Very soon, NBA themed promotions and experience zones will be launched in India. The announcement...

Dunzo to Raise Funds from Google, others

Dunzo, the app which is trying to make life easier for the people upto some extent plans to raise about Rs. 183 crore from different investors which a...

Sapta Shakti Command Will Be Displaying Defence Technology Equipment at Jaipur Military Station

This event is organised with an aim to provide an opportunity where one and all can experience the developments in the field of defence and security-r...

Samsung is All Set to Roll out Its Galaxy A9 Smartphone On November 20

After Samsung unveiled its new Galaxy A9 smartphone in Singapore last month, the company is all set to launch it in India on November 20. In Singapore...

RECOMMENDED